Candriam SCA’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-5,000
Closed -$237K – 819
2023
Q1
$237K Hold
5,000
– – ﹤0.01% 862
2022
Q4
$261K Hold
5,000
– – ﹤0.01% 843
2022
Q3
$283K Hold
5,000
– – ﹤0.01% 854
2022
Q2
$303K Hold
5,000
– – ﹤0.01% 759
2022
Q1
$295K Sell
5,000
-5,000
-50% -$285K ﹤0.01% 766
2021
Q4
$575K Hold
10,000
– – ﹤0.01% 738
2021
Q3
$535K Buy
+10,000
New +$625K ﹤0.01% 781

Other funds holding NHI

Candriam SCA's NHI Position: Q2 2023 in Review

Candriam SCA sold out of National Health Investors (NHI) in Q2 2023, closing a stake of 5,000 shares — an estimated $237K sold.

Candriam SCA first reported a position in NHI in Q3 2021 and held it in 7 quarters. The position peaked at $575K in Q4 2021. 211 funds tracked by Wall St. Rank hold NHI as of Q2 2023.

  • Candriam SCA reported no remaining National Health Investors position as of Q2 2023 after selling out during the quarter.
  • Candriam SCA sold 5,000 National Health Investors shares in Q2 2023, an estimated $237K.
  • Candriam SCA first reported a position in National Health Investors in Q3 2021 and held it in 7 quarters.
  • Candriam SCA's National Health Investors position peaked at $575K in Q4 2021.
  • 211 funds tracked by Wall St. Rank held National Health Investors as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.